We are supported by readers, when you click & purchase through links on our site we earn affiliate commission. Learn more.

NewView Capital leads $22.3M Sequence B in Australian telehealth platform Eucalyptus

Telehealth platform Eucalyptus raised a $22.3 million Sequence B spherical of funding to construct a digital well being portfolio for major care in Australia.

NewView Capital led the spherical with participation from present traders Blackbird Ventures and W23, and new investor AirTree Ventures. As a part of the funding, Ravi Viswanathan, NewView founder and managing accomplice, might be becoming a member of the Eucalyptus board.

The brand new spherical provides the Sydney-based firm a complete of $32.8 million raised because it was based in 2019 by Tim Doyle, Benny Kleist, Alexey Mitko and Charlie Gearside.

Australia’s healthcare system is a two-payer mannequin, the place a lot of the care is paid for by the federal government, and there’s a smaller insurance coverage protection that’s owned by people. Eucalyptus suits into these fashions as a private-pay possibility promoting on to shoppers. In some circumstances, the corporate is ready to cost decrease copays for care than the common $25 per physician go to, Doyle instructed TechCrunch.

He touts the corporate because the “largest vertically built-in telehealth platform in Australia,” serving greater than 200,000 sufferers throughout 4 demographic-focused manufacturers: contraception and fertility, skincare, males’s well being and sexual wellness. Every model has its personal core platform of healthcare suppliers, affected person information repository, distant monitoring instruments and partnerships with pathology labs and pharmacies.

All of that ends in a better contact and better high quality relationship between physician and affected person, Doyle mentioned.

“We’re seeing a possibility to shorten the period of time between identification of a situation and analysis,” he added. “We additionally need to go extra in-depth into diabetes, coronary heart situations and psychological well being. Persons are dropping out of diabetes and psychological care as a result of there are usually not sufficient contact factors which are straightforward to make use of. If we will construct a hub, it’ll make it simpler to deal with these situations.”

Along with product improvement, the brand new funding permits Eucalyptus to construct towards being a serious participant within the telehealth trade. The corporate will introduce new manufacturers within the subsequent yr round continual care like behavioral well being, weight administration and diabetes.

Eucalyptus greater than tripled its final yr and expects related development this yr, Doyle mentioned. This isn’t not like different startups within the digital well being sector, the place 2020 noticed one other document yr for enterprise capital funding. He additionally expects so as to add workers to assist that development, from 80 to 100 by the tip of the yr.

In the meantime, Doyle mentioned he’s excited to work with NewView, particularly with Viswanathan and principal Christina Fa, who mentioned Eucalyptus is proving that Australia can lead in digital healthcare.

“The workforce is spectacular by way of readability of imaginative and prescient and execution, particularly in the best way they introduced in folks to handle the manufacturers,” she instructed TechCrunch. “It’s distinctive being based mostly in Australia the place they don’t have Teladoc and different digital well being firms. As an alternative, Eucalyptus needed to construct all of that in-house and do the arduous work upfront. As well as, they curated a community of well being suppliers and 4 manufacturers, every with their very own personalities. This enables them to be absolutely vertically built-in and personal the shopper journey.”

8 VCs agree: Behavioral assist and distant visits make digital well being a robust wager for 2022